FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
A Zantac cancer lawsuit filed in California will go before a jury in November, however no specific case has yet been selected, according to a Reuters report.
A Zantac bladder cancer lawsuit scheduled to go to trial next month in California has been resolved through a confidential settlement agreement, GlaxoSmithKline says.
A California judge will allow Zantac lawsuits to move forward after allowing plaintiffs' expert witnesses to testify.
A House lawmaker is asking FDA whether it plans to investigate GlaxoSmithKline for potentially hiding cancer risks from Zantac for decades in order to maintain profits.
An investigative report indicates GlaxoSmithKline knew Zantac could transform into NDMA, a known cancer-causing chemical, since the drug was first developed, but never told the FDA.
Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
All Chantix recall cancer lawsuits are to be consolidated in a southern New York federal court for pretrial proceedings.
Despite dismissal of federal Zantac lawsuits, plaintiffs continue to file claims in state courts.
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…